Aquatic Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-76,568
| Closed | -$3.64M | – | 1375 |
|
|
2025
Q3 | $3.64M | Buy |
76,568
+27,175
| +55% | +$1.32M | 0.07% | 343 |
|
|
2025
Q2 | $2.64M | Sell |
49,393
-23,381
| -32% | -$1.06M | 0.05% | 402 |
|
|
2025
Q1 | $2.95M | Buy |
72,774
+54,733
| +303% | +$2.32M | 0.08% | 327 |
|
|
2024
Q4 | $502K | Buy |
18,041
+14,841
| +464% | +$449K | 0.01% | 717 |
|
|
2024
Q3 | $91.8K | Buy |
+3,200
| New | +$83.4K | ﹤0.01% | 935 |
|
|
2024
Q2 | – | Sell |
-19,800
| Closed | -$500K | – | 1181 |
|
|
2024
Q1 | $500K | Buy |
+19,800
| New | +$476K | 0.02% | 544 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$34K | – | 1321 |
|
|
2022
Q3 | $34K | Buy |
1,000
+100
| +11% | +$1.53K | ﹤0.01% | 937 |
|
|
2022
Q2 | $9K | Buy |
900
+300
| +50% | +$3.13K | ﹤0.01% | 979 |
|
|
2022
Q1 | $9K | Buy |
+600
| New | +$10.5K | 0.01% | 678 |
|
